C

Craig B. Thompson

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0003-3580-2751

Publishes on Cancer, Hypoxia, and Metabolism, T-cell and B-cell Immunology, Immune Cell Function and Interaction. 764 papers and 207.5k citations.

PubIndex Score98Top 2%How it's scored

🌟#4 Current Senior Leader in Histone Deacetylase Inhibitors Research 🌟#5 Current Senior Leader in Cancer, Hypoxia, and Metabolism 🌟#8 Current Senior Leader in Cell death mechanisms and regulation 🌟#9 Current Senior Leader in Phagocytosis and Immune Regulation

764Publications

207.5kTotal Citations

#4in Histone Deacetylase Inhibitors Research

First publication: 1912First senior author: 1987

Cancer, Hypoxia, and Metabolism T-cell and B-cell Immunology Immune Cell Function and Interaction Cell death mechanisms and regulation Epigenetics and DNA Methylation

Top publicationsby citations

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Tilman Oltersdorf, Saul H. Rosenberg, Steven W. Elmore et al.|Nature|2005

Cited by 3.4k

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

María E. Figueroa, Ari Melnick, Omar Abdel‐Wahab et al.|Cancer Cell|2010

Cited by 2.7k

Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma

Ravi K. Amaravadi, Craig B. Thompson|Journal of Clinical Investigation|2007

Cited by 1.1k

Tumor suppressors and cell metabolism: a recipe for cancer growth

Russell G. Jones, Craig B. Thompson|Genes & Development|2009

Cited by 1.1k

Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth

Monica Buzzai, Craig B. Thompson|Cancer Research|2007

Cited by 917